Welte, T, Dellinger, RP, Ebelt, H, Ferrer, M, Opal, SM, Singer, M, Vincent, J-L, Werdan, K, Martin-Loeches, I, Almirall, J, Artigas, A, Ignacio Ayestaran, J, Nuding, S, Ferrer, R, Sirgo Rodriguez, G
, Shankar-Hari, M, Alvarez-Lerma, F, Riessen, R, Sirvent, J-M, Kluge, S, Zacharowski, K, Bonastre Mora, J, Lapp, H, Woebker, G, Achtzehn, U, Brealey, D, Kempa, A, Sanchez Garcia, M, Brederlau, J, Kochanek, M, Reschreiter, HP, Wise, MP, Belohradsky, BH, Bobenhausen, I, Dalken, B, Dubovy, P, Langohr, P, Mayer, M, Schuettrumpf, J, Wartenberg-Demand, A, Wippermann, U, Wolf, D & Torres, A 2018, '
Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)',
Intensive Care Medicine, vol. 44, no. 4, pp. 438-448.
https://doi.org/10.1007/s00134-018-5143-7